Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
Highlights
- Drug induced parkinsonism caused by valbenazine and deutetrabenazine.
- Possible side effects of VMAT-2 inhibitors.
- Valbenazine and deutetrabenazine can unmask underlying Parkinson’s Disease.
Document Type
Article
Publication Date
11-7-2020
Digital Object Identifier (DOI)
https://doi.org/10.1016/j.prdoa.2020.100078
Repository Citation
Vasireddy, Rani Priyanka; Sokola, Brent; and Guduru, Zain, "New Generation VMAT2 Inhibitors Induced Parkinsonism" (2020). Neurology Faculty Publications. 58.
https://uknowledge.uky.edu/neurology_facpub/58
1-s2.0-S2590112520300463-mmc1.docx (12 kB)
Supplementary data 1
1-s2.0-S2590112520300463-mmc2.zip (87 kB)
Supplementary data 2
1-s2.0-S2590112520300463-mmc3.mp4 (16150 kB)
Supplementary video 3
Supplementary data 1
1-s2.0-S2590112520300463-mmc2.zip (87 kB)
Supplementary data 2
1-s2.0-S2590112520300463-mmc3.mp4 (16150 kB)
Supplementary video 3
Notes/Citation Information
Published in Clinical Parkinsonism & Related Disorders, v. 3, 100078.
© 2020 The Author(s)
This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).